Evidence map›Paper›PMID 27043716›Full record

ArticlePloS one2016

Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators.

Laura V Minard, Heidi Deal, Megan E Harrison, Kent Toombs, Heather Neville, Andrea Meade

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Key performance indicators for pharmaceutical services: A systematic review.Exploratory research in clinical and social pharmacy · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Optimizing Patient Education of Oncology Medications: A Patient Perspective.Journal of cancer education : the official journal of the American Association for Cancer Education · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura V MinardDepartment of Pharmacy, Nova Scotia Health Authority, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.
Heidi DealCollege of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada.
Megan E HarrisonCollege of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada.
Kent ToombsDepartment of Pharmacy, Nova Scotia Health Authority, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.
Heather NevilleDepartment of Pharmacy, Nova Scotia Health Authority, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.
Andrea MeadeDepartment of Pharmacy, Nova Scotia Health Authority, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn hospitals around the world, there has been no consensus regarding which clinical activities a pharmacist should focus on until recently. In 2011, a Canadian clinical pharmacy key performance indicator (cpKPI) collaborative was formed. The goal of the collaborative was to advance pharmacy practice in order to improve patient outcomes and enhance the quality of care provided to patients by hospital pharmacists. Following a literature review, which indicated that pharmacists can improve patient outcomes by carrying out specific activities, and an evidence-informed consensus process, a final set of eight cpKPIs were established. Canadian hospitals leading the cpKPI initiative are currently in the early stages of implementing these indicators.

objectiveTo explore pharmacists' perceptions of the barriers and facilitators to the implementation of cpKPIs.

methodsClinical pharmacists employed by the Nova Scotia Health Authority were invited to participate in focus groups. Focus group discussions were audio-recorded and transcribed, and data was analyzed using thematic analysis.

findingsThree focus groups, including 26 pharmacists, were conducted in February 2015. Three major themes were identified. Resisting the change was comprised of documentation challenges, increased workload, practice environment constraints, and competing priorities. Embracing cpKPIs was composed of seeing the benefit, demonstrating value, and existing supports. Navigating the unknown was made up of quality versus quantity battle, and insights into the future.

conclusionsAlthough pharmacists were challenged by documentation and other changes associated with the implementation of cpKPIs, they demonstrated significant support for cpKPIs and were able to see benefits of the implementation. Pharmacists came up with suggestions for overcoming resistance associated with the implementation of cpKPIs and provided insights into the future of pharmacy practice. The identification of barriers and facilitators to cpKPI implementation will be used to inform the implementation process on a local and national level.

Indexed as

PerceptionPharmacistsQuality Indicators, Health CareAttitude of Health PersonnelDocumentationFocus GroupsHumansNova ScotiaPharmaciesPharmacy Service, HospitalQualitative ResearchSurveys and QuestionnairesWorkload

Identifiers

PMID27043716
PMCPMC4820256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.